Skip to content

Immune modulator N-803 does not control HIV rebound, suggesting a combination approach is needed for a functional cure

A close-up of a syringe and a vaccine bottle.

African paediatric studies at CROI: HIV remission in children, three bnAbs in babies, two years on injectables in teens

Dr Gabriela Cromhout at CROI 2026. She is standing behind a lectern, talking into a microphone.

Half the participants from placebo arm of HIV cure trial have prolonged viral load remission when given broadly neutralising antibodies

Professor John Frater at CROI 2026. He is being interviewed at the CROI conference centre.

Dual immune modulators delay, but don’t prevent, HIV rebound after stopping antiretrovirals

Dr Ana Gabriela Pires Dos Santos at CROI 2026. She is sitting down, with a small microphone in front of her.

CD8 cell fitness predicts who benefits most from antibody-based cure strategies

Illustration of HIV cells in pink and purple.

Second Berlin patient has unusual immune response that seems to have removed his HIV

Timo Trenkner presenting at EACS 2025. Timo is standing at a podium, talking into a microphone, with a screen and panel of people next to him.

Turning HIV’s power against itself may help target hidden virus – another step towards a cure

Close-up of a researcher working in a lab. She is wearing white surgical gloves and a white lab coat.

Broadly neutralising antibodies plus immune modulator may delay HIV rebound

An IV infusion drip.

Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect

A woman in a white coat and blue gloves in a laboratory holds a pipette.